Are cytokines ready for prime time? Insights from markers and trials

Cardiovascular (CV) disease remains a leading source of morbidity and mortality worldwide. Over recent decades, it has become apparent that clinical risk factors alone do not neatly capture the individual risk profile for future CV events. This unmet need has created an impetus for the discovery of biomarkers reflective of the underlying disease pathophysiology that can provide a personalized approach to risk stratification and risk modification. An additional value of biomarker discovery is that they do not just track a response to therapy but can potentially suggest novel therapeutic targets.
Source: Trends in Cardiovascular Medicine - Category: Cardiology Authors: Tags: Editorial Source Type: research